AwardedSpainGoods€272,796
Suministro de medicamentos Pomalidomida, Fumarato de Dimetilo, Eribulina y Hierro Carboximaltosa con pérdida de comercialización exclusiva con destino a los centros hospitalarios del Sector de Huesca.
- Published
- Published 24 June 2025
- Deadline
- Closed 23 July 2025
Overview
The Huesca Health Sector procured supply of four pharmaceutical products—Pomalidomide, Dimethyl Fumarate, Eribulin, and Iron Carboxymaltose—with loss of exclusive marketing rights for hospital centres in the Huesca sector. The contract was awarded on 10 October 2025 to a consortium of four suppliers (ACCORD HEALTHCARE, SLU; EVER Pharma Therapeutics Spain SL; Sandoz Farmaceutica; and TEVA PHARMA SLU) for a value of €109,226.90.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €272,796
- Procedure
- Open
- Published
- 24 June 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €109,227
- Award date
- 10 October 2025
- Contract period
- — → 10 October 2026
- ACCORD HEALTHCARE, SLU
- EVER Pharma Therapeutics Spain SL
- Sandoz Farmaceutica
- TEVA PHARMA SLU
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
18 November 2025
Contract Notice
24 June 2025
Contracting authority
Gerencia Sector Sanitario de Huesca
Procuring entityHuesca, Spain
ID_PLATAFORMA: 20997570143517
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.